47 related articles for article (PubMed ID: 24408160)
1. Controversies in central nervous system prophylaxis of high-risk diffuse large B-cell lymphoma.
Bobillo S; Wilson MR; Cwynarski K
Curr Opin Oncol; 2023 Sep; 35(5):382-388. PubMed ID: 37551947
[TBL] [Abstract][Full Text] [Related]
2. Primary lymphoma of the female genital tract masquerading as gynecological malignancy.
Shi S; Li W; Ni G; Ding J; Liu Y; Wu H; Zhang Z; Ding Z
BMC Womens Health; 2024 Apr; 24(1):247. PubMed ID: 38637800
[TBL] [Abstract][Full Text] [Related]
3. Mesonephric adenocarcinomas in female genital tract: A case series.
Xie C; Chen Q; Shen Y
Medicine (Baltimore); 2021 Sep; 100(35):e27174. PubMed ID: 34477176
[TBL] [Abstract][Full Text] [Related]
4. Primary B-Cell lymphoma of the uterine cervix presenting with right ureter hydronephrosis: A case report.
Del M; Angeles MA; Syrykh C; Martínez-Gómez C; Martínez A; Ferron G; Gabiache E; Oberic L
Gynecol Oncol Rep; 2020 Nov; 34():100639. PubMed ID: 32995453
[TBL] [Abstract][Full Text] [Related]
5. Lactic acid alleviates stress: good for female genital tract homeostasis, bad for protection against malignancy.
Witkin SS
Cell Stress Chaperones; 2018 May; 23(3):297-302. PubMed ID: 29063375
[TBL] [Abstract][Full Text] [Related]
6. Have we reached the end of the road for radiation therapy in primary central nervous system lymphoma?
Kaliyath SB; Sharma DN
J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S1018-S1019. PubMed ID: 38261455
[No Abstract] [Full Text] [Related]
7. Primary diffuse large B-cell tumor of the uterus: a case report.
Zhang Z; Yang Q
Front Med (Lausanne); 2023; 10():1234861. PubMed ID: 37521344
[TBL] [Abstract][Full Text] [Related]
8. Management of Primary Uterine Cervix B-Cell Lymphoma Stage IE and Fertility Sparing Outcome: A Systematic Review of the Literature.
Stabile G; Ripepi C; Sancin L; Restaino S; Mangino FP; Nappi L; Ricci G
Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509340
[TBL] [Abstract][Full Text] [Related]
9. Advanced Ann Arbor stage and age over 60 years as prognostic predictors in patients with primary cervical lymphoma: a retrospective cohort study and systematic review.
Gao L; Chen X; Zhao J; Xu A; Liu M; Yu H; Kong S; Li S
BMC Cancer; 2023 Jan; 23(1):95. PubMed ID: 36707772
[TBL] [Abstract][Full Text] [Related]
10. Predictive impact of soluble interleukin-2 receptor and number of extranodal sites for identification of patients at very high risk of CNS relapse in diffuse large B-cell lymphoma.
Shichijo T; Tatetsu H; Nosaka K; Higuchi Y; Kikukawa Y; Inoue Y; Toyoda K; Yasunaga JI; Matsuoka M
EJHaem; 2022 May; 3(2):385-393. PubMed ID: 35846027
[TBL] [Abstract][Full Text] [Related]
11. Lymphoma of the female genital tract: a clinicopatholngical analysis of 25 cases.
Wang J; Zeng L; Chen S; Wu Q; Ma L; Wu S; Wang ZP; Tao Y; Chai D
Am J Transl Res; 2019; 11(9):5800-5811. PubMed ID: 31632549
[TBL] [Abstract][Full Text] [Related]
12. Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System Recurrence.
Ollila TA; Olszewski AJ
Curr Treat Options Oncol; 2018 Jun; 19(8):38. PubMed ID: 29931605
[TBL] [Abstract][Full Text] [Related]
13. Extranodal involvement in young patients with diffuse large B-cell lymphoma: distribution, prognostic value and treatment options.
Yao S; Li J; Yao Z; Xu Y; Chu J; Zhang J; Jin S; Huang Y; Zhang J; Ma J; Zhao Y; Yang S; Liu Y
Chin J Cancer Res; 2017 Feb; 29(1):57-65. PubMed ID: 28373754
[TBL] [Abstract][Full Text] [Related]
14.
Sasikumar A; Joy A; Pillai MR; Thomas B
Indian J Nucl Med; 2017; 32(1):54-56. PubMed ID: 28242988
[TBL] [Abstract][Full Text] [Related]
15. Primary diffuse large B-cell lymphoma of the ovary is of a germinal centre B-cell-like phenotype.
Sun J; Zhang J; Ling Q; Luo Y; Wu S; Liang Z; Zhong D; Zeng X
Virchows Arch; 2015 Jan; 466(1):93-100. PubMed ID: 25403088
[TBL] [Abstract][Full Text] [Related]
16. Patients with primary diffuse large B-cell lymphoma of female genital tract have high risk of central nervous system relapse.
Cao XX; Li J; Zhang W; Duan MH; Shen T; Zhou DB
Ann Hematol; 2014 Jun; 93(6):1001-5. PubMed ID: 24408160
[TBL] [Abstract][Full Text] [Related]
17. Impact of central nervous system (CNS) prophylaxis on the incidence and risk factors for CNS relapse in patients with diffuse large B-cell lymphoma treated in the rituximab era: a single centre experience and review of the literature.
Guirguis HR; Cheung MC; Mahrous M; Piliotis E; Berinstein N; Imrie KR; Zhang L; Buckstein R
Br J Haematol; 2012 Oct; 159(1):39-49. PubMed ID: 22849793
[TBL] [Abstract][Full Text] [Related]
18. Risk-tailored CNS prophylaxis in a mono-institutional series of 200 patients with diffuse large B-cell lymphoma treated in the rituximab era.
Ferreri AJ; Bruno-Ventre M; Donadoni G; Ponzoni M; Citterio G; Foppoli M; Vignati A; Scarfò L; Sassone M; Govi S; Caligaris-Cappio F
Br J Haematol; 2015 Mar; 168(5):654-62. PubMed ID: 25312994
[TBL] [Abstract][Full Text] [Related]
19. A retrospective analysis of primary gastric diffuse large B-cell lymphoma with or without concomitant mucosa-associated lymphoid tissue (MALT) lymphoma components.
Li X; Xia B; Guo S; Zhan Z; Zhang L; Zhao D; Wu X; Zhang Y
Ann Hematol; 2013 Jun; 92(6):807-15. PubMed ID: 23417758
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
